Icosavax was founded in November 2017.
Icosavax is incorporated in Delaware.
Icosavax’s headquarters is:
1616 Eastlake Avenue E., Suite 208
Seattle, Washington 98102
You can view our Board of Directors by visiting the Board of Directors section of our website.
You can view our management team by visiting the Executive Team section of our website.
Ernst & Young LLP
Icosavax is traded on the Nasdaq Global Market (NASDAQ) under the symbol “ICVX”.
Icosavax went public on July 29, 2021.
Shares can be purchased through a stockbroker of your choice.
Icosavax does not offer a direct stock purchase plan.
Currently, Icosavax does not offer a dividend or a dividend reinvestment program.
Icosavax’s CUSIP number is: 45114M 109
P.O. Box 505005
Louisville, KY 40233-5005
You must send both your old and new addresses to our transfer agent, Computershare, by U.S. mail. Each stockholder in question must sign the request for an address change. For more information and address change forms, contact Computershare by telephone at 1-800-564-6253. or go to www.computershare.com
You can view our recent press releases by visiting the Press Releases section of our website.
For media inquiries please send an email to firstname.lastname@example.org.
You can view information on our development programs by visiting the Pipeline section of our website.
For investor related questions please send an email to email@example.com.
Please visit the Investor Relations section of our corporate website and fill out our web form to be added to the Icosavax distribution list.
To request additional information, please visit our Contact Us page.